CIK 0000748592
- Non-accelerated filer
- Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 311103425
- Phone
- +1 617-798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Unregistered share sale · Director nominations
- 8-K Event Bylaws or fiscal year change
- 8-K Event Material agreement · New debt or obligation
- 10-K Report Annual Report
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Director nominations
- 8-K Event Delisting notice · Executive or director change
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Unregistered share sale · Shareholder vote results · Other events
- 8-K Event Material agreement · Agreement ended
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 8-K Event Delisting notice
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 8-K Event Delisting notice
- 10-K/A Report 10-K/A
Page 2 of 26 · 505 filings